title: Stage III and IV Hodgkin's disease treatment guidelines. American College of Radiology. ACR Appropriateness Criteria.
authors.affiliation: Duke University Medical Center, Durham, NC, USA.
authors.forename: L R
authors.initials: LR
authors.lastname: Prosnitz
authors.forename: J M
authors.initials: JM
authors.lastname: Connors
authors.forename: R L
authors.initials: RL
authors.lastname: Deming
authors.forename: J
authors.initials: J
authors.lastname: Yahalom
authors.forename: P M
authors.initials: PM
authors.lastname: Mauch
authors.forename: L S
authors.initials: LS
authors.lastname: Constine
authors.forename: D E
authors.initials: DE
authors.lastname: Dosoretz
authors.forename: A J
authors.initials: AJ
authors.lastname: Elman
authors.forename: R T
authors.initials: RT
authors.lastname: Hoppe
authors.forename: D A
authors.initials: DA
authors.lastname: Pistenmaa
authors.forename: H B
authors.initials: HB
authors.lastname: Wolkov
authors.forename: A
authors.initials: A
authors.lastname: Chauvenet
authors.forename: J H
authors.initials: JH
authors.lastname: Glick
authors.forename: S
authors.initials: S
authors.lastname: Leibel
mesh_terms: D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D006801:Humans; D009367:Neoplasm Staging; D015996:Survival Rate; D016896:Treatment Outcome